« previous next »
Pages: [1]

Author Topic: (Abst.) A longitudinal study of symptom botheration in MS  (Read 33 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) A longitudinal study of symptom botheration in MS
« on: December 13, 2020, 09:50:14 pm »

I'm not sure just what the word "botheration" means here unless it's the extent to which a patient is being bothered by MS symptoms. 

From PubMed (December 12, 2020)--"A longitudinal study of symptom botheration in multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/33296981/



Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
4 Replies
199 Views 		Last post April 11, 2017, 07:11:54 pm
by agate
0 Replies
62 Views 		Last post September 20, 2018, 08:36:29 am
by agate
1 Replies
93 Views 		Last post August 12, 2019, 06:47:51 am
by agate
0 Replies
33 Views 		Last post June 03, 2021, 08:37:51 pm
by agate
0 Replies
25 Views 		Last post December 18, 2021, 08:51:29 pm
by agate